133 related articles for article (PubMed ID: 18056201)
1. Alteration of cellular and humoral immunity by mutant p53 protein and processed mutant peptide in head and neck cancer.
Couch ME; Ferris RL; Brennan JA; Koch WM; Jaffee EM; Leibowitz MS; Nepom GT; Erlich HA; Sidransky D
Clin Cancer Res; 2007 Dec; 13(23):7199-206. PubMed ID: 18056201
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.
Chikamatsu K; Sakakura K; Takahashi G; Okamoto A; Furuya N; Whiteside TL; DeLeo AB; Masuyama K
Cancer Immunol Immunother; 2009 Sep; 58(9):1441-8. PubMed ID: 19184003
[TBL] [Abstract][Full Text] [Related]
3. A wild-type sequence p53 peptide presented by HLA-A24 induces cytotoxic T lymphocytes that recognize squamous cell carcinomas of the head and neck.
Eura M; Chikamatsu K; Katsura F; Obata A; Sobao Y; Takiguchi M; Song Y; Appella E; Whiteside TL; DeLeo AB
Clin Cancer Res; 2000 Mar; 6(3):979-86. PubMed ID: 10741724
[TBL] [Abstract][Full Text] [Related]
4. Evidence that HLA class II-restricted human CD4+ T cells specific to p53 self peptides respond to p53 proteins of both wild and mutant forms.
Fujita H; Senju S; Yokomizo H; Saya H; Ogawa M; Matsushita S; Nishimura Y
Eur J Immunol; 1998 Jan; 28(1):305-16. PubMed ID: 9485210
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
6. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules.
Mustafa AS; Shaban FA; Al-Attiyah R; Abal AT; El-Shamy AM; Andersen P; Oftung F
Scand J Immunol; 2003 Feb; 57(2):125-34. PubMed ID: 12588658
[TBL] [Abstract][Full Text] [Related]
7. The wild-type sequence (wt) p53(25-35) peptide induces HLA-DR7 and HLA-DR11-restricted CD4+ Th cells capable of enhancing the ex vivo expansion and function of anti-wt p53(264-272) peptide CD8+ T cells.
Ito D; Albers A; Zhao YX; Visus C; Appella E; Whiteside TL; DeLeo AB
J Immunol; 2006 Nov; 177(10):6795-803. PubMed ID: 17082593
[TBL] [Abstract][Full Text] [Related]
8. CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck.
Andrade Filho PA; Ito D; Deleo AB; Ferris RL
Cancer Immunol Immunother; 2010 Oct; 59(10):1561-8. PubMed ID: 20577877
[TBL] [Abstract][Full Text] [Related]
9. Immunological characterization of missense mutations occurring within cytotoxic T cell-defined p53 epitopes in HLA-A*0201+ squamous cell carcinomas of the head and neck.
Ito D; Visus C; Hoffmann TK; Balz V; Bier H; Appella E; Whiteside TL; Ferris RL; DeLeo AB
Int J Cancer; 2007 Jun; 120(12):2618-24. PubMed ID: 17294448
[TBL] [Abstract][Full Text] [Related]
10. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
[TBL] [Abstract][Full Text] [Related]
11. Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53.
Rojas JM; McArdle SE; Horton RB; Bell M; Mian S; Li G; Ali SA; Rees RC
Cancer Immunol Immunother; 2005 Mar; 54(3):243-53. PubMed ID: 15449037
[TBL] [Abstract][Full Text] [Related]
12. Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
Karbach J; Pauligk C; Bender A; Gnjatic S; Franzmann K; Wahle C; Jäger D; Knuth A; Old LJ; Jäger E
Int J Cancer; 2006 Feb; 118(3):668-74. PubMed ID: 16152624
[TBL] [Abstract][Full Text] [Related]
13. Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Hoffmann TK; Donnenberg AD; Finkelstein SD; Donnenberg VS; Friebe-Hoffmann U; Myers EN; Appella E; DeLeo AB; Whiteside TL
Cancer Res; 2002 Jun; 62(12):3521-9. PubMed ID: 12067999
[TBL] [Abstract][Full Text] [Related]
14. Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.
Nisini R; Paroli M; Accapezzato D; Bonino F; Rosina F; Santantonio T; Sallusto F; Amoroso A; Houghton M; Barnaba V
J Virol; 1997 Mar; 71(3):2241-51. PubMed ID: 9032359
[TBL] [Abstract][Full Text] [Related]
15. Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants.
Hoffmann TK; Nakano K; Elder EM; Dworacki G; Finkelstein SD; Appella E; Whiteside TL; DeLeo AB
J Immunol; 2000 Nov; 165(10):5938-44. PubMed ID: 11067956
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of CD4
Hyun YS; Jo HA; Lee YH; Kim SM; Baek IC; Sohn HJ; Cho HI; Kim TG
Front Immunol; 2020; 11():602014. PubMed ID: 33658991
[TBL] [Abstract][Full Text] [Related]
17. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
[TBL] [Abstract][Full Text] [Related]
18. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay.
Stuber G; Leder GH; Storkus WT; Lotze MT; Modrow S; Székely L; Wolf H; Klein E; Kärre K; Klein G
Eur J Immunol; 1994 Mar; 24(3):765-8. PubMed ID: 8125143
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.
Ichiki Y; Takenoyama M; Mizukami M; So T; Sugaya M; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
J Immunol; 2004 Apr; 172(8):4844-50. PubMed ID: 15067062
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQB1 alleles may influence the surface expression of DQ molecules in lymphomononuclear cells of type 1 diabetes mellitus patients.
Fernandes AP; Foss MC; Donadi EA
Scand J Immunol; 2004 Mar; 59(3):305-9. PubMed ID: 15030582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
